The DOI matches its Crossref record; 249 of the 249 references it cites were found in a registry or an index.
Cytotoxicity of dietary flavonoids on different human cancer types
Open accessAbstract
Flavonoids are ubiquitous in nature. They are also in food, providing an essential link between diet and prevention of chronic diseases including cancer. Anticancer effects of these polyphenols depend on several factors: Their chemical structure and concentration, and also on the type of cancer. Malignant cells from different tissues reveal somewhat different sensitivity toward flavonoids and, therefore, the preferences of the most common dietary flavonoids to various human cancer types are analyzed in this review. While luteolin and kaempferol can be considered as promising candidate agents for treatment of gastric and ovarian cancers, respectively, apigenin, chrysin, and luteolin have good perspectives as potent antitumor agents for cervical cancer; cells from main sites of flavonoid metabolism (colon and liver) reveal rather large fluctuations in anticancer activity probably due to exposure to various metabolites with different activities. Anticancer effect of flavonoids toward blood cancer cells depend on their myeloid, lymphoid, or erythroid origin; cytotoxic effects of flavonoids on breast and prostate cancer cells are highly related to the expression of hormone receptors. Different flavonoids are often preferentially present in certain food items, and knowledge about the malignant tissue-specific anticancer effects of flavonoids could be purposely applied both in chemoprevention as well as in cancer treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–249 of 249
Harris, D. M., Li, L., Chen, M. F., Lagunero, F. T., Go, V. L. W., & Boros, L. G. (2011) · Metabolomics · doi:10.1007/s11306-011-0300-9 · Cited by 66
Wesołowska, O., Wiśniewski, J. Ł., Środa-Pomianek, K., Bielawska‐Pohl, A., Paprocka, M., Duś, D., Duarte, N., Ferreira, M. U., & Michalak, K. (2012) · Journal of Natural Products · doi:10.1021/np3003468 · Cited by 65
Tsui, K., Chung, L., Feng, T., Chang, P., & Juang, H. (2011) · International Journal of Cancer · doi:10.1002/ijc.26284 · Cited by 65
Bulzomi, P., Bolli, A., Galluzzo, P., Acconcia, F., Ascenzi, P., & Marino, M. (2012) · IUBMB Life · doi:10.1002/iub.1049 · Cited by 65
Selective apoptotic effects of piceatannol and myricetin in human cancer cells
Morales, P., & Haza, A. I. (2011) · Journal of Applied Toxicology · doi:10.1002/jat.1725 · Cited by 63
Hsiao, Y.-C., Hsieh, Y., Kuo, W., Chiou, H., Yang, S., Chiang, W.-L., & Chu, S. (2006) · Journal of Biomedical Science · doi:10.1007/s11373-006-9117-3 · Cited by 63
Cheng, Y.-H., Li, L., Lin, P., Cheng, L.-C., Hung, C., Chang, N. W., & Lin, C. (2012) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2012.07.010 · Cited by 63
Choi, S. I., Jeong, C. S., Cho, S. Y., & Lee, Y. S. (2007) · Archives of Pharmacal Research · doi:10.1007/bf02980274 · Cited by 62
Fu, J., Chen, D., Zhao, B., Zhao, Z., Zhou, J., Xu, Y., Xin, Y., Liu, C., Luo, L., & Yin, Z. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049194 · Cited by 62
Bestwick, C. S., Milne, L., & Duthie, S. J. (2007) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2007.07.002 · Cited by 61
Flavones inhibit the proliferation of human tumor cancer cell lines by inducing apoptosis
Kilani, S., Martel‐Frachet, V., Bhouri, W., Ghédira, K., Ghédira, L. C., & Ronot, X. (2011) · Drug and Chemical Toxicology · doi:10.3109/01480545.2011.564180 · Cited by 61
Involvement of bax/bcl-2 in wogonin-induced apoptosis of human hepatoma cell line SMMC-7721
Wang, W., Guo, Q., You, Q., Zhang, K., Yang, Y., Yu, J., Liu, W., Zhao, L., Gu, H.-Y., Hu, Y., et al. (2006) · Anti-Cancer Drugs · doi:10.1097/01.cad.0000217431.64118.3f · Cited by 58
Nazari, M., Ghorbani, A., Hekmatdoost, A., Jeddi‐Tehrani, M., & Zand, H. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.10.053 · Cited by 58
Yu, J. S., & Kim, A. K. (2011) · Molecules and Cells · doi:10.1007/s10059-011-0041-7 · Cited by 58
Chen, W.-Y., Hsieh, Y.-A., Tsai, C.-I., Kang, Y.-F., Chang, F., Wu, Y., & Wu, C. (2010) · Investigational New Drugs · doi:10.1007/s10637-010-9497-0 · Cited by 57
Ishii, K., Tanaka, S., Kagami, K., Henmi, K., Toyoda, H., Kaise, T., & Hirano, T. (2009) · Cancer Investigation · doi:10.3109/07357900902744486 · Cited by 56
Cytotocic effect of plant polyphenols and fat-soluble vitamins on malignant human cultured cells
Ramanathan, R., Tan, C. H., & Das, N. P. (1992) · Cancer Letters · doi:10.1016/0304-3835(92)90099-h · Cited by 56
Lee, E.-R., Kang, Y.-J., Choi, H.-Y., Kang, G., Kim, J., Kim, B., Han, Y. S., Nah, S.-Y., Paik, H., Park, Y.-S., et al. (2007) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.30.2394 · Cited by 56
Baicalein, a Novel Apoptotic Agent for Hepatoma Cell Lines:A Potential Medicine for Hepatoma
Chen, C., Huang, L. L. H., Huang, C.-C., Lin, C., Lee, Y., & Lu, F.-J. (2000) · Nutrition and Cancer · doi:10.1207/s15327914nc382_19 · Cited by 55
Shieh, D., Cheng, H., Yen, M., Chiang, L., & Lin, C. (2006) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x06003801 · Cited by 49
Strouch, M. J., Milam, B. M., Melstrom, L. G., McGill, J. J., Salabat, M. R., Ujiki, M. B., Ding, X.-Z., & Bentrem, D. J. (2009) · Pancreas · doi:10.1097/mpa.0b013e318193a074 · Cited by 47
Comparative Antioxidant, Prooxidant and Cytotoxic Activity of Sigmoidin A and Eriodictyol
Habtemariam, S., & Dagne, E. (2009) · Planta Medica · doi:10.1055/s-0029-1240604 · Cited by 46
Luteolin suppresses growth and migration of human lung cancer cells
Zhao, Y., Yang, G., Ren, D., Zhang, X., Qiuwei, Y., & Sun, X. (2010) · Molecular Biology Reports · doi:10.1007/s11033-010-0208-x · Cited by 46
Induction of caspase-dependent, p53-mediated apoptosis by apigenin in human neuroblastoma
Torkin, R., Lavoie, J.-F., Kaplan, D. R., & Yeger, H. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.1.4.1 · Cited by 46
Wang, T., Wang, S., Huang, G.-L., & Sun, G. (2012) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2012.13.11.5455 · Cited by 43
Iwuchukwu, O. F., Tallarida, R. J., & Nagar, S. (2011) · Life Sciences · doi:10.1016/j.lfs.2011.03.016 · Cited by 42
Proteomic identification of anti-cancer proteins in luteolin-treated human hepatoma Huh-7 cells
Yoo, D. R., Jang, Y. H., Jeon, Y. K., Kim, J. Y., Jeon, W., Choi, Y. J., & Nam, M. J. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.02.051 · Cited by 42
Potential Effects of Chrysin on MDA-MB-231 Cells
Hong, T. B., Rahumatullah, A., Yogarajah, T., Ahmad, M., & Khoo, B. Y. (2010) · International Journal of Molecular Sciences · doi:10.3390/ijms11031057 · Cited by 42
Influence of Flavonoids on Cell Cycle Phase as Analyzed by Flow-Cytometry
Koide, T., Kamei, H., Hashimoto, Y., Kojima, T., Terabe, K., & Umeda, T. (1997) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.1997.12.111 · Cited by 40
Regulation of apoptosis by modified naringenin derivatives in human colorectal carcinoma RKO cells
Lee, E., Kang, Y., Kim, H., Choi, H., Kang, G., Kim, J., Kim, B., Jeong, H., Park, Y., & Cho, S. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21622 · Cited by 40
Fisetin induces apoptosis in Huh-7 cells via downregulation of BIRC8 and Bcl2L2
Kim, J. Y., Jeon, Y. K., Jeon, W., & Nam, M. J. (2010) · Food and Chemical Toxicology · doi:10.1016/j.fct.2010.05.058 · Cited by 39
Wei, L., Lu, N., Dai, Q., Rong, J., Chen, Y., Li, Z., You, Q., & Guo, Q. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22898 · Cited by 39
Seibert, H., Maser, E., Schweda, K., Seibert, S., & Gülden, M. (2011) · Food and Chemical Toxicology · doi:10.1016/j.fct.2011.06.055 · Cited by 38
Haddad, A., Fleshner, N. E., Nelson, C. C., Saour, B., Musquera, M., Venkateswaran, V., & Klotz, L. H. (2010) · Nutrition and Cancer · doi:10.1080/01635581003605524 · Cited by 38
Xu, M. J., Lu, N., Zhang, H., Dai, Q., Wei, L., Li, Z., You, Q., & Guo, Q. (2012) · Hepatology Research · doi:10.1111/hepr.12036 · Cited by 37
Wu, J., Yi, W., Jin, L., Hu, D., & Song, B. (2012) · Cell Division · doi:10.1186/1747-1028-7-20 · Cited by 37
Tundis, R., Loizzo, M. R., Menichini, F., Bonesi, M., Colica, C., & Menichini, F. (2011) · Chemistry & Biodiversity · doi:10.1002/cbdv.201000311 · Cited by 34
Apoptosis induced by baicalin involving up-regulation of P53 and bax in MCF-7 cells
Wang, N., Tang, L.-J., Zhu, G., Peng, D., Wang, L., Sun, F., & Li, Q. (2008) · Journal of Asian Natural Products Research · doi:10.1080/10286020802410664 · Cited by 34
Antitumor constituents from the leaves of Carya cathayensis.
Cao, X., Ding, Z., Jiang, F., Ding, X., Chen, J., Chen, S., & Lv, G. (2012) · PubMed · doi:10.1080/14786419.2011.628174 · Cited by 30
Zhang, M., Liu, L.-P., Chen, Y., Tian, X.-Y., Qin, J., Wang, D., Li, Z., & Mo, S. (2012) · Life Sciences · doi:10.1016/j.lfs.2012.10.023 · Cited by 29
Chen, Y., Chen, H.-Y., Hsu, C., & Yen, G. (2007) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf063118t · Cited by 28
Role of Baicalein in the regulation of proliferation and apoptosis in human myeloma RPMI8226 cells
Li, Q., Yong, Y. O. U., Chen, Z., Lu, J., Shao, J., & Zou, P. (2006) · Chinese Medical Journal · doi:10.1097/00029330-200606010-00012 · Cited by 25
Lust, S., Vanhoecke, B. W. A., Gele, M. V., Philippé, J., Bracke, M., & Offner, F. C. (2010) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200900186 · Cited by 24
Protection of p53 Wild Type Cells From Taxol by Genistein in the Combined Treatment of Lung Cancer
Tokalov, S. V., Abramyuk, A. M., & Abolmaali, N. (2010) · Nutrition and Cancer · doi:10.1080/01635581003605912 · Cited by 22
Jaiswal, J. V., Wadegaonkar, P. A., & Hajare, S. W. (2012) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-012-9646-3 · Cited by 22
Ai, X. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i28.3824 · Cited by 21
Comparative Anticancer Effects of Flavonoids and Diazepam in Cultured Cancer Cells
Kim, D.-H., Lee, J., Lee, I., & Ha, J. (2008) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.31.255 · Cited by 20
Role of transglutaminase 2 in quercetin-induced differentiation of B16-F10 murine melanoma cells
Forni, C., Braglia, R., Lentini, A., Nuccetelli, M., Provenzano, B., Tabolacci, C., & Beninati, S. (2008) · Amino Acids · doi:10.1007/s00726-008-0158-y · Cited by 14
Boik, J. C., & Newman, R. A. (2008) · BMC Pharmacology · doi:10.1186/1471-2210-8-13 · Cited by 13
Cited by
Anti-inflammatory effects of flavonoids
Maleki, S. J., Crespo, J. F., & Cabanillas, B. (2019) · Food Chemistry · doi:10.1016/j.foodchem.2019.125124 · Cited by 1,249
Flavonoids in Cancer and Apoptosis
Abotaleb, M., Samuel, S., Varghese, E., Varghese, S., Kubatka, P., Liskova, A., & Büsselberg, D. (2018) · Cancers · doi:10.3390/cancers11010028 · Cited by 751
Enhancement of the gut barrier integrity by a microbial metabolite through the Nrf2 pathway
Singh, R., Chandrashekharappa, S., Bodduluri, S. R., Baby, B. V., Hegde, B., Kotla, N. G., Hiwale, A. A., Saiyed, T., Patel, P., Vijay-Kumar, M., et al. (2019) · Nature Communications · doi:10.1038/s41467-018-07859-7 · Cited by 713
Understanding of ROS-Inducing Strategy in Anticancer Therapy
Kim, S. J., Kim, H. S., & Seo, Y. R. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/5381692 · Cited by 406
Natural product-based nanoformulations for cancer therapy: Opportunities and challenges
Kashyap, D., Tuli, H. S., Yerer, M. B., Sharma, A., Sak, K., Srivastava, S., Pandey, A., Garg, V. K., Sethi, G., & Bishayee, A. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.08.014 · Cited by 390
Self-citation
Metadata
- Authors
- Sak, K.
- Venue
- Pharmacognosy Reviews
- Publisher
- Manuscript Technomedia LLP
- Published
- 2014
- Volume
- 8
- Issue
- 16
- Pages
- 122
- ISSN
- 0973-6581 (ISSN-L)
- 0973-7847
- OpenAlex
- W2146984617
- Cited by
- 461
- References
- 249
- FWCI
- 34.20
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.